Q&A With Klaus Marten From Bayer Healthcare: New Autoinjector Aims to Help Patients With Multiple Sclerosis Receive Treatment Safely

Video

Patients with multiple sclerosis are no strangers to taking medication for their condition at various times. A new autoinjector recently approved by the FDA hopes to help patients with that process with updated technology and other features to make the process more streamlined and less painful.

Patients with multiple sclerosis are no strangers to taking medication for their condition at various times. A new autoinjector recently approved by the FDA hopes to help patients with that process with updated technology and other features to make the process more streamlined and less painful.

Klaus Marten, from Bayer Healthcare discussed how improvements in technology allowed the new autoinjector to be developed during the annual ECTRIMS congress in Barcelona.

Related Videos
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
Stephanie Nahas, MD, MSEd | Credit: Jefferson Health
John Harsh, PhD: Exploring Once-Nightly Sodium Oxybate Therapy for Narcolepsy
John Harsh, PhD
© 2024 MJH Life Sciences

All rights reserved.